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Summary Congenital generalized lipodystrophy (CGL)
is an autosomal recessive metabolic syndrome with
involvement of multiple organs. Mutations in BSCL2
are known to be associated with a severe form of CGL
and mental retardation (MR). The genetic heteroge-
neity in CGL patients is accompanied by phenotypic
heterogeneity in different ethnic groups. Studies in the
Indian context are very few in this regard. We report
here a detailed clinical analysis of a CGL case from
infancy to adult hood. Interestingly, the patient was
found to be homozygous for a novel BSCL2 mutation,
but with normal intellectual development contrasting
with the MR associated with BSCL2 mutation in CGL
patients. The biochemical investigations at the time of
diagnosis (9 months) included total cholesterol, total
lipids, triglycerides, phospholipids, b-lipoprotein and
free fatty acids, which were above normal limits.
The clinical phenotype, viz. lack of subcutaneous fat,
hepatosplenomegaly, cardiomegaly, and advanced
bone age was also documented. The patient was found
to be insulin resistant and diabetes mellitus was
diagnosed by age 13 years. Ultrasonography of the
ovaries at age 22 showed polycystic features with
elevated levels of gonadotropins and negligible levels
of serum leptin. For genetic analysis, direct DNA
sequencing of BSCL2 was carried out and disclosed an
11-base-pair deletion in exon 6 (H217fsX272) resulting
in a truncated protein. This is a novel mutation that
contributes to CGL formation in a family of Indian
origin and adds to the array of variants reported in this
disorder. Moreover, the novel mutation is found to be
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Congenital generalized lipodystrophy (CGL; OMIM
269700) is also known as Berardinelli–Seip syndrome.
It is a rare metabolic disorder inherited as an auto-
somal recessive trait (Garg 2000). The pattern of body
fat loss is unique, i.e. near-total absence of metaboli-
cally active adipose tissue in subcutaneous, intra-
abdominal, intra-thoracic, and bone marrow regions,
but preservation of mechanical fat in the orbits, palms,
soles, scalp, perineum, and periarticular regions (Garg
et al 1992). Even during infancy patients show hyper-
insulinaemia, hypertriglyceridaemia and hepatomegaly
because of hepatic steatosis. More clinical features
include widespread acanthosis nigricans, acromegaloid
appearance, umbilical hernia and in women, clitero-
megaly, hirsutism, oligo/amenorrhoea and polycystic
ovaries. Diabetes mellitus develops mostly during the
pubertal years and is ketosis resistant. Other reported
features involve mild mental retardation, hypertrophic
cardiomyopathy, nephropathy, and nubecula (Agarwal
et al 2002; Van Maldergem et al 2002).
CGL is classified into three types, viz. BSCL-1,
BSCL-2 and BSCL-X based on the phenotype and the
genotype. One of the first genes identified to be
associated with CGL phenotype was AGPAT2 linked
to 9q34. Subsequently, Magre and colleagues (Magre
et al 2001) studied 29 families of CGL and identified a
second locus on chromosome 11 within the 2.5 Mb
interval flanked by markers D11S4076 and D11S480.
This locus had the gene called BSCL2. Subsequently,
a number of homozygous and heterozygous mutations
in the BSCL2 gene were identified (van Maldergem
et al 2002). Since, cases harbouring BSCL2 muta-
tions had a phenotype different from those having
AGPAT2 mutations, CGL was subclassified as CGL:
BSCL-2.
Mutations in BSCL2 gene have been reported from
Europe, the Middle East and Japan and recently in
Chinese subject with CGL (Magre et al 2001). While
the clinical features of cases of CGL from the Indian
subcontinent have been reported, the genetic alter-
ations that may occur in these patients have not been
investigated in most cases (Kher et al 1990; Mandal
et al 2006). Moreover, the changes in phenotype that
occur at puberty in CGL have not been reported. In
the present study, we report the clinical phenotype of a
patient with CGL from infancy to adulthood. We also
report the presence of a novel mutation in the BSCL2
gene of this patient.
Case presentation and analysis
Case report/clinical phenotype
The female patient was referred to the Genetic
Research Centre of our Institute at the age of 9 months
for genetic evaluation. She was born at term to non-
consanguineous Hindu parents. On physical exam-
ination at 9 months, her head circumference was
43 cm (>50th centile) and height was 76 cm (>90th
centile). Her forehead was small with a mop of hair
and she had peculiar pinched facies (Figs. 1, 2). A lack
of subcutaneous fat and hyperpigmentation with
acanthosis nigricans around the neck and axilla was
seen. The body was hirsute with prominent muscula-
ture and phlebomegaly. Biochemical investigations at
the time of diagnosis revealed that serum was lipaemic
with cholesterol 7.254 mmol/L (279 mg/dl), total lipids
7.55 mmol/L (755 mg/dl), triglycerides 1.936 mmol/L
(176 mg/dl) and phospholipids 3.00 mmol/L (300 mg/dl).
Her b-lipoprotein was 1.75 mmol/L (67.6 mg/dl)
free fatty acids were 1730 mmol/L (173 mg/dl). A skin
biopsy showed absence of adipose tissue. Systemic
examination also revealed hepatosplenomegaly and
mild cardiomegaly. Her bone age was advanced
(2.5 years). Examinations of gastrointestinal system
and renal systems were unremarkable.
The patient was evaluated every year and diagnosis
of insulin resistance and diabetes mellitus was made
through her follow-up at the age of 13 years. Hence
she was kept on strict low-fat diet and supplementa-
tion of fish oil was started at age 13 years. This fish
oil treatment improved her skin texture and improve-
ment in hirsutism was seen with disappearance of
acanthosis nigricans. The lipaemia of the serum was
also reduced.
At 22 years of age (Fig. 3B) during her follow-up,
ultrasonography of the ovaries showed polycystic
features. Sex hormones at the age of 22 years showed
elevated FSH (32 mIU/ml), LH (12.8 mIU/ml) and
negligible leptin levels (0.03 ng/ml). Serum 17-OH-
progesterone level was normal. She did not show
any signs of mental retardation and studied up to
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graduation level with average performance. Her mid-
parental height was 1.55 m, whereas the measured
height at adulthood was 1.67 m. The patient died at the
age of 29 years due to renal failure.
Genetic analysis
For the genetic analysis, blood was collected at age
22 years with informed consent. DNA was extracted
Fig. 2 (A) Patient at 2 years of age. The forehead is small and head circumference is >50th centile. The body is bony and hirsute with
prominent musculature and the patient requires support to stand. (B) Closer (facial) view at 2 years of age. Acanthosis nigricans
clearly visible at the axillary region (indicated by arrow). The head is big with a mop of hair and typical pinched facies
Fig. 1 Patient at 9 months of age
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from peripheral blood leukocytes using Gene Elute
extraction protocol (Sigma, St Louis, MO, USA). The
extracted DNA was analysed both qualitatively as well
as quantitatively. A part of this extracted DNA was
sent to the laboratory of Dr L. Van Maldergem,
Belgium, for analysis of BSCL2 gene.
The analysis of BSCL2 gene revealed a homozygous
11 bp deletion in exon 6 (Fig. 4B). This deletion was
Fig. 4 (A) Wild-type partial sequence of exon 6 of BSCL2 gene from a control subject. (B) Partial sequence of exon 6 of BSCL2 gene
of the CGL patient, showing 11 bp deletion
Fig. 3 (A) The patient at 16 years of age. (B) The patient at 22 years of age. The fish oil treatment improved her skin texture and
improvement in hirsutism was seen with disappearance of acanthosis nigricans
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predicted to result in a frameshift giving a truncated
protein that would lack 130 amino acids from its
C-terminal end. To the best of our knowledge this
mutation H217fsX272 in BSCL2 has not previously
been described in any case with CGL.
Discussion
The CGL case described here has all the clinical
features classically described by Maldergem and col-
leagues (Van Maldergem 2001) except mental retar-
dation, and this is the first report of a novel 11 bp
deletion in the BSCL2 gene in CGL patients.
CGL is a rare autosomal recessive condition with
involvement of multiple organs such as brain, pan-
creas, spleen, liver, adipose tissue, bones and cardiac
system (Garg 2004). The patient reported here dis-
played at birth the classical features of CGL, mainly
absence of subcutaneous fat with acanthosis nigricans
and advanced bone age. Her biochemical status of
hyperlipidaemia was evident from the elevated levels
of lipids. The occurrence of diabetes mellitus was evi-
dent around the age of puberty. The patient suffered
from oligoamenorrhoea and had typical signs of
polycystic ovary syndrome (PCOS). All these features
have been described for CGL (Garg 2004). Interest-
ingly, the physical features of acanthosis nigricans and
hyperpigmentation including hirsutism could be con-
trolled by treatment with fish oil and low-fat diet,
suggesting that the monitoring of dietary regimes and
inclusion of essential supplements could form part of
the management of this congenital disorder.
Two main genes have been implicated in the
aetiology of CGL. These include AGPAT2 and
BSCL2 (Downes et al 1998; Magre et al 2001; Simha
and Garg 2003). However, the mutations observed in
these two genes show distinct ethnic and racial dis-
tribution. While AGPAT2 mutations have been prev-
alent in African and American CGL cases, BSCL2
mutations have been observed in families from Euro-
pean, Afro-Asian and Middle-Eastern countries
(Ebihara et al 2004). In keeping with these observa-
tions, in the present study we identified a novel 11 bp
deletion in the BSCL2 gene of this patient. To date,
19 mutations have been identified in BSCL2 gene,
most of which have an inactivating effect (Agarwal
et al 2003). The mutation reported here would also be
of inactivating type because it induces premature stop
codon, thereby removing 130 amino acids from the
C-terminal end. From the Indian subcontinent, Mandal
and colleagues have reported three different muta-
tions in the BSCL2 gene of CGL patients from India
(Mandal et al 2006). The mutation reported here adds
to the BSCL2 variants reported in this disorder.
One clinical feature that distinguishes CGL patients
harbouring BSCL2 mutations from those with AGPAT2
mutations is the occurrence of mental retardation. It has
been reported that cases with BSCL2 mutations gener-
ally have mental retardation whereas those with
AGPAT2 mutations are intellectually normal. In con-
trast to this generalization, the patient we reported
harbours a BSCL2 mutation but is mentally normal.
Beyond the general social ability to perform, this
patient was also intellectually competent as she success-
fully completed her graduation at an age expected for
the average Indian student (22–23 years). This observa-
tion is striking since most cases ($80%) harbouring
BSCL2 mutations are known to have mental retarda-
tion. However, it is important to note that such normal
intellectual ability has been reported in an Indian
patient (Van Maldergem et al 2002) and Japanese
patients with CGL and BSCL2 mutations (Ebihara
et al 2004). These observations indicate that mental
retardation may not be associated with BSCL2 muta-
tion but may be a result of modifying environmental
and other genetic influences (Fu et al 2004)
In summary, the CGL patient reported here harbours
a novel 11 bp deletion mutations in exon 6 of BSCL2
gene that is not associated with mental retardation,
emphasizing the phenotypic heterogeneity of this meta-
bolic disorder. Functional studies of BSCL2 gene and
its protein product will provide greater insights into the
mechanism of pathogenesis of this disorder.
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